Abstract
Fourteen patients with disseminated breast cancer with primary or secondary resistance to tamoxifen were treated with LY156758. There were no complete or partial responses and 1 patient showed a minor response. These data illustrate that LY156758 did not have significant antitumor activity in patients previously treated with tamoxifen therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 344-345 |
| Number of pages | 2 |
| Journal | Oncology (Switzerland) |
| Volume | 45 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1988 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Phase II evaluation of LY156758 in metastatic breast cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS